Aytu BioPharma, Inc. (LON:0A8M)
London · Delayed Price · Currency is GBP · Price in USD 2.200
+0.520 (30.95%)
At close: May 16, 2025
Aytu BioPharma Market Cap
Aytu BioPharma has a market cap or net worth of 21.4 million as of January 8, 2026. Its market cap has increased by 216.73% in one year.
Market Cap
21.40M
Enterprise Value
18.26M
Revenue
47.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since April 22, 2015, Aytu BioPharma's market cap has decreased from 48.94M to 21.40M, a decrease of -56.28%. That is a compound annual growth rate of -7.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 21.40M | 8.73% |
| Dec 31, 2025 | 19.68M | 135.70% |
| Dec 31, 2024 | 8.35M | -32.73% |
| Dec 29, 2023 | 12.41M | 26.76% |
| Dec 30, 2022 | 9.79M | -65.10% |
| Dec 31, 2021 | 28.06M | -64.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 207.55B |
| HSBC Holdings | 206.99B |
| Shell | 156.59B |
| Unilever | 104.05B |
| Rio Tinto Group | 103.95B |
| Rolls-Royce Holdings | 103.08B |
| British American Tobacco p.l.c. | 88.35B |
| GSK plc | 73.04B |